SEKURE Creatine Kinase Assay
Nad Reduction/Nadh Oxidation, Cpk Or Isoenzymes. 510(k) K182702, from Sekisui Diagnostics P.E.I., Inc. (Charlottetown,, CA). Product code CGS, class 2.
As of Nov 18, 2026, K182702 is an FDA 510(k) held by Sekisui Diagnostics P.E.I., Inc., substantially equivalent on Apr 17, 2019 after 202 days, with no recalls tied to it in FDA's recall database.
- Review time: 202 days
- Recalls: 0
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 27, 2018
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1215
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files